---
title: Hypertension
author: J. Austin Straley, DO
date: 2024-03-16
categories:
    - Cardiology
---
- [Management](https://pubmed.ncbi.nlm.nih.gov/29146535/){:target="_blank"}
    - [DASH: Small but significant BP reductions from diet control](http://www.ncbi.nlm.nih.gov/pubmed/9099655){:target="_blank"}
    - [LIFE: Losartan > Atenolol for same BP Reduction](https://pubmed.ncbi.nlm.nih.gov/11937179/){:target="_blank"}
    - [ALLHAT: Thiazide = CCB = ACEI in High-risk HTN, Thiazides may be better](https://pubmed.ncbi.nlm.nih.gov/12479763/){:target="_blank"}
    - [ACCOMPLISH: CCBs > Diuretics when added to ACEI in High-risk HTN](https://pubmed.ncbi.nlm.nih.gov/19052124/){:target="_blank"}
    - [Thiazides less effective in obese, CCBs equal across weight](https://pubmed.ncbi.nlm.nih.gov/23219284/){:target="_blank"}
    - [HOPE: ACEI significantly reduces rate of HF in High-risk patients](https://pubmed.ncbi.nlm.nih.gov/12628949/){:target="_blank"}
    - Inpatient
        - [Asymptomatic Inpatient Hypertension](https://pubmed.ncbi.nlm.nih.gov/30811320/){:target="_blank"}
        - [Things We Do For No Reason: Antihypertensives Inpatient](https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.13185){:target="_blank"}
        - [Hydralazine vs. Labetalol Inpatient](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673377/){:target="_blank"}
    - [Resistant Hypertension](https://pubmed.ncbi.nlm.nih.gov/27895136/){:target="_blank"}